Yin Minyi, Wang Wei, Huang Xintian, Hong Biao, Liu Xiaobing, Li Weimin, Lu Xinwu, Lu Min, Jiang Mier
Department of Vascular Surgery, Shanghai Ninth People's Hospital, Shanghai JiaoTong University School of Medicine, 639 Zhizaoju Rd, Shanghai, 200011, China.
Department of Vascular Surgery, Tong Ren Hospital, Shanghai JiaoTong University School of Medicine, 768 Yuyuan Rd, Shanghai, 200050, China.
Cardiovasc Intervent Radiol. 2015 Dec;38(6):1468-76. doi: 10.1007/s00270-015-1119-y. Epub 2015 May 15.
The study aimed to evaluate the feasibility, safety, and outcome of endovascular recanalization of native chronic total occlusions (CTO) in patients with critical limb ischemia (CLI) and lower extremities bypass graft failure.
A retrospective review of CLI patients with failed lower limb grafts (>30 days after surgery) that underwent recanalization of native CTO was conducted in two institutions from January 2010 to June 2014. Twenty-eight patients (28 limbs) were included in the study, and all had limited surgical revascularization options. Demographics, procedural data, technical success, complications, vessel patency, limb salvage rates, and survival rates were analyzed.
The mean follow-up period was 12.8 months. The technical success rate was 92.9% (26/28 limbs). The combined ipsilateral antegrade-retrograde approach was performed in nine limbs (32.1%). Major periprocedural (<30 days) complications included two myocardial infarctions (7.1%) and two stent thromboses (7.1%), resulting in one amputation. The ankle brachial index before discharge was significantly improved after recanalization (0.78 ± 0.08 vs. 0.31 ± 0.10, p < 0.01). The primary, assisted primary, and secondary patency rates at 12 months were 52.2, 65.8, and 82.2%, respectively. The limb salvage rate and amputation-free survival rate at 12 months were 91.6 and 87.0%, respectively.
Endovascular recanalization of native CTO in patients with graft failure-related CLI is a feasible, safe, and effective procedure, with reasonable technical success, vessel patency, and limb salvage rates. The technique should be attempted before amputation in patients with limited surgical revascularization options.
本研究旨在评估对严重肢体缺血(CLI)且下肢旁路移植失败患者的自体慢性完全闭塞病变(CTO)进行血管内再通治疗的可行性、安全性及疗效。
对2010年1月至2014年6月在两家机构接受自体CTO再通治疗的下肢移植失败(术后>30天)的CLI患者进行回顾性分析。纳入28例患者(28条肢体),所有患者的手术血运重建选择均有限。分析患者的人口统计学资料、手术数据、技术成功率、并发症、血管通畅情况、肢体挽救率及生存率。
平均随访期为12.8个月。技术成功率为92.9%(26/28条肢体)。九条肢体(32.1%)采用了同侧顺行-逆行联合入路。围手术期(<30天)主要并发症包括两例心肌梗死(7.1%)和两例支架血栓形成(7.1%),导致一例截肢。再通后出院前踝肱指数显著改善(0.78±0.08对0.31±0.10,p<0.01)。12个月时的一期、辅助一期和二期通畅率分别为52.2%、65.8%和82.2%。12个月时的肢体挽救率和无截肢生存率分别为91.6%和87.0%。
对移植失败相关CLI患者的自体CTO进行血管内再通是一种可行、安全且有效的手术,具有合理的技术成功率、血管通畅率和肢体挽救率。对于手术血运重建选择有限的患者,应在截肢前尝试该技术。